Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.
- NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_assertion description "[We examined the effects of the mammalian target of rapamycin inhibitor, rapamycin, on mammary tumorigenesis in transgenic mice bearing an activated ErbB2 (NeuYD) transgene in the absence or presence of a second transgene encoding vascular endothelial growth factor (VEGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.
- NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_assertion evidence source_evidence_literature NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.
- NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_assertion SIO_000772 15958580 NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.
- NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_assertion wasDerivedFrom befree-2016 NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.
- NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_assertion wasGeneratedBy ECO_0000203 NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.
- befree-2016 importedOn "2016-02-19" NP499734.RA_UR3Uu0ZgnkJSN_PjPK8yVbybdCin1NX9tjTZrhA2Vo130_provenance.